CDK9 and cancer: To comprehensively investigate the therapeutic potential of targeting CDK9 in solid tumors, we analyzed the drug screening data from the Cancer Therapeutics Response Portal (CTRP) to identify associations between CDK9 expression and drug sensitivity.